Drugs / Sitagliptin/Simvastatin FDC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01678820 | Oct 2012 → Nov 2013 | type 2 diabetes mellitus | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sitagliptin/Simvastatin FDC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01678820 ↗ |
| Route | Oral | “administered orally once daily in the evening” NCT01678820 ↗ |